CompletedNCT00938743
Official study titleDriving Ability in Adults With ADHD Before and After 10-weeks of Treatment With 40-80mg Atomoxetine vs. Untreated Adults With ADHD
This study has finished and is no longer accepting participants.
In MannheimADHDMedication studyAges 18–55
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
CompletedNCT00807222
Official study titleStudy of the Effect of Vyvanse (Lisdexamfetamine Dimesylate) on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Clinical Study Centers, LLC
CompletedNCT00291070
Official study titleA Double Blind, Randomized Placebo Controlled Clinical Trial Examining the Effects of L-Theanine (Suntheanine®) in Male Child Subjects With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In CoquitlamADHDMedication studyAges 8–12
- Countries
- Canada
- Sponsor
- University of British Columbia
CompletedNCT00409708
Official study titleAn Open-label, Behavioral-treatment-controlled Evaluation of the Effects of Extended Release Methylphenidate on the Frequency of Cytogenetic Abnormalities in Children 6 - 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In HoustonADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Novartis
CompletedNCT01439126
What is this study about?This study evaluated the safety and effectiveness of clonidine hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–17
- Countries
- Sponsor
- Concordia Pharmaceuticals Inc., Barbados
CompletedNCT00482313
What is this study about?This study evaluated the effectiveness of PR OROS Methylphenidate for people with ADHD.
This study has finished and is no longer accepting participants.
In HuddingeADHDMedication studyAges 18–65
- Countries
- Sweden
- Sponsor
- Psychiatry Karolinska
CompletedNCT00191945
Official study titleA Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 Weeks in Newly Diagnosed Children and Adolescents Outpatients With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BadajozADHDMedication studyAges 6–15
- Countries
- Spain
- Sponsor
- Eli Lilly and Company
CompletedNCT00776009
Official study titleA Randomized, Multi-center, Double-blind, Placebo-controlled, Cross-over Study Evaluating the Safety and Efficacy of Dex-Methylphenidate Extended Release 30 mg vs. 20 mg as Measured by SKAMP-Combined Scores in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Novartis Pharmaceuticals
WithdrawnNCT01207622
What is this study about?This study evaluates the effectiveness of Atomoxetine for people with ADHD.
This study was withdrawn before enrollment.
In CambridgeADHD, AddictionMedication studyAges 15–30
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01270555
What is this study about?This study evaluated the effectiveness of Bupropion SR for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHD, AddictionMedication studyAges 18–60
- Countries
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00318448
Official study titleEfficacy, Safety and Tolerability of Zolpidem in the Treatment of Children Aged 6 to 17 Years With ADHD-Associated Insomnia. A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study
This study has finished and is no longer accepting participants.
Multiple locations, including BridgewaterADHDMedication studyAges 6–17
- Countries
- United States, Canada
- Sponsor
- Sanofi
WithdrawnNCT02154321
Official study titleEEG and ADHD Study
This study was withdrawn before enrollment.
In Ann ArborADHDObservational studyAges 18–35
- Countries
- United States
- Sponsor
- University of Michigan